Home
NewsNewsTulsa Fertility Center partners with Pinnacle Fertility to unite its longstanding clinical excellence with Pinnacle’s national network, delivering advanced technology, personalized care, and expanded support services to patients across Oklahoma.
A leader in the Reproductive Drugs and also one of the most respected fertility practices operating in Oklahoma since 1988 Tulsa Fertility Center partners with Pinnacle Fertility, Inc, as a nationally recognized network when it comes to fertility clinics. This partnership unites the expansive, patient-centered network of Pinnacle with the longstanding excellence in fertility care of Tulsa Fertility Center, thereby making sure that more patients all across the region get access to treatments that are innovative and also compassionate support in their journey that leads to parenthood.
Shauna McKinney, MD, a fellowship-trained reproductive endocrinology and infertility - REI specialist leads the Tulsa Fertility Center. She is a native Oklahoman and is known for her expertise when it comes to minimally invasive gynecologic surgery, advanced fertility treatments including IVF, ICSI, and genetic screening, as well as endometriosis and fibroid care.
Dr. McKinney, due to her past work and expertise, is committed to helping patients go past the infertility challenges like PCOS, premature ovarian failure, and also recurrent pregnancy loss by way of evidence-based and customized care.
Dr. McKinney says that she chose Pinnacle Fertility, the leader in reproductive drugs, due to the fact that it enables them to deliver care that is highly personal and powered by leading-edge technology. Due to the fact that Pinnacle has a collaborative network and the expertise that’s shared throughout its Medical and Lab Leadership Boards, their patients go on to benefit from innovation, which is bound to improve final outcomes. As per Dr. McKinney, this partnership brings the best of both worlds to Oklahoma, i.e., advanced resources as well as personalized care, which defines the very essence of Tulsa Fertility Center.
It is well to be noted that as part of the Pinnacle Fertility network, Tulsa Fertility Center now happens to have access to national resources that elevate both patient as well as provider experience, including the shared physician innovation boards, integrated clinical data systems, and also advanced laboratory technologies that are designed to enhance outcomes and also streamline care. The comprehensive ecosystem that Pinnacle has also happens to include Pinnacle Egg Bank and Pinnacle Surrogacy, as well as its own mental health program, which offers patients and physicians very easy access to third-party reproduction, surrogacy, and also emotional wellness support and that too within a single coordinated network.
According to the CEO of Pinnacle Fertility, Inc., Beth Zoneraich, Tulsa Fertility Center and Dr. McKinney offer an exceptional quality of care and compassion, which define the mission of Pinnacle. They are indeed proud to welcome this incredible practice into their growing network as they continue to expand access to world-class fertility care across the country. Their commitment is to empower physicians as well as clinics such as Tulsa Fertility Center with resources, technology, and also a collaborative infrastructure that is required to roll out the best possible results for their patients throughout the U.S.
Fertility care leader IVI RMA North America announces a new partnership with Island Reproductive Services
Overture Life’s DaVitri fertility automation platform gains CE Mark, paving the way for wider IVF and egg freezing access in Europe.
Simbryo Technologies introduces the Simbryo FX personalized assay, a diagnostic test that measures endometrial fertility to predict embryo implantation success and improve IVF outcomes with more than 90% specificity.
Technology-Enabled Cryostorage is transforming fertility storage as Reprotech and TMRW combine expertise in digital specimen management and biorepository services. The partnership enhances scalability, safety, and efficiency while supporting clinics with advanced solutions. This strategic move positions the combined company to lead innovation and meet growing global demand in cryostorage services.
CDSCO Orders on IVF Medical Devices reinforce strict regulatory oversight across India’s fertility sector. The directive mandates licensing compliance under existing laws, ensuring IVF and ART devices meet safety and quality standards. This move aims to curb unauthorized sales, strengthen enforcement, and bring greater accountability to medical device usage in reproductive healthcare.
The Tennessee State Law could change how the embryos are handled at the time of treatment, thereby making the IVF clinic services in the state more expensive for patients seeking fertility care.
Before taking a call on IVF, survey conducted in the U.S., UK, Ireland, and Canada suggests that people are looking for complete & less expensive options to treat root causes of infertility.
